JD Health International Inc.
6618
Kedudukan dalam Saham
#1399
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Harga Saham
$4.98
Modal Pasaran
$15.89B
Perubahan (1 hari)
-2.21%
Perubahan (1 tahun)
-39.77%
Negara
CN
Perdagangan JD Health International Inc. (6618)
Kategori
Healthcare
Nisbah P/E bagi JD Health International Inc. (6618)
Nisbah P/E pada October 2026 TTM: 16.71
Menurut laporan kewangan dan harga saham terkini JD Health International Inc., nisbah P/E semasa (TTM) ialah 16.71. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 50.90.
Sejarah nisbah P/E bagi JD Health International Inc. dari 2017 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 16.71 | -16.42% |
| 2024 | 19.99 | -60.72% |
| 2023 | 50.90 | -90.12% |
| 2022 | 514.97 | -454.91% |
| 2021 | -145.10 | 803.28% |
| 2020 | -16.06 | -92.61% |
| 2019 | -217.32 | -115.47% |
| 2018 | 1.40K | -12.41% |
| 2017 | 1.60K | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 15.70 | -6.02% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -37.77% |
US
|
|
| 32.07 | 91.93% |
SA
|
|
| 20.00 | 19.70% |
BR
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.